Catimanan, Rizal -.

HRN: 26-38-72  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2025
CEFUROXIME 750MG (VIAL)
12/20/2025
12/27/2025
IV
350mg
Q8h
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines